GlaxoSmithKline Nigeria, a top manufacturer and distributor of healthcare products in Africa’s biggest economy says the worsening shortage of foreign exchange in the country is hurting its ability to maintain a consistent supply of drugs and vaccines to the Nigerian market.
Omongiade Ehighebolo
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
Josephine Okojie-Okeiyi
Josephine Okojie-Okeiyi is a journalist with over five years’ reporting experience. She writes on industry, agriculture, commodities, climate change, and environmental issues.
She is fellow of Thomson Reuters Foundation and Bloomberg Media Initiative for Africa.
